EZH2 expression in colorectal carcinoma: an evaluation of clinicopathological and prognostic value
Abstract Background Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of Polycomb Repressive Complex 2, catalyzes trimethylation of histone H3 lysine 27 and has been implicated in tumor progression. Aim Our study aims to assess the relationship between EZH2 expression and clinicopathologic d...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02990-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|